NCT05400876penpulimabTQB2618cHLr/r cHLr/r lymphoma
…nducted from June 2022 to September 2024 at 12 sites in China ( NCT05400876). The study included a dose-escalation phase in which patients …
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05400876 ×
NCT05400876
This institution is selected. Its supporting articles are shown below.